This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Boston Scientific Neuromodulation Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Pratap Arangil: Innovator in Electrical Stimulation Technology
Introduction
Pratap Arangil is a notable inventor based in Valencia, CA, who has made significant contributions to the field of electrical stimulation technology. With a focus on innovative medical devices, he has developed solutions that enhance patient care and treatment options.
Latest Patents
Arangil holds a patent for "Electrical stimulation cuff devices and systems with helical arrangement of electrodes." This invention features an electrical stimulation lead that includes a cuff with a body having an exterior surface, an interior surface, and a circumference. The cuff contains longitudinally elongated electrodes that are helically arranged, allowing for effective stimulation of target nerves. A longitudinal slit extends through the cuff body, enabling the cuff to receive a portion of a target nerve from outside to within the cuff body. This innovative design enhances the functionality and effectiveness of electrical stimulation therapies.
Career Highlights
Pratap Arangil is associated with Boston Scientific Neuromodulation Corporation, where he has contributed to the development of advanced medical technologies. His work focuses on improving the quality of life for patients through innovative solutions in neuromodulation.
Collaborations
Throughout his career, Arangil has collaborated with esteemed colleagues, including Arthur J. Foster and Hari Hara Subramanian. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Pratap Arangil's contributions to electrical stimulation technology exemplify the impact of innovation in the medical field. His patented inventions and collaborative efforts continue to advance the capabilities of neuromodulation therapies, ultimately benefiting patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
